Impact Biomedical (IBO) Net Shares Issued and Repurchased (2023 - 2025)

Impact Biomedical (IBO) has reported Net Shares Issued and Repurchased for 3 consecutive years, with $18.0 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased changed 0.0% year-over-year to $18.0 million; the trailing twelve-month figure through Dec 2025 stood at $18.0 million (changed 0.0% YoY), and the FY2025 full-year result was $18.0 million, changed 0.0% from the prior year.
• Net Shares Issued and Repurchased steadied at $18.0 million in Q4 2025 per IBO's latest filing, from $18.0 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $18.8 million in Q4 2023 and bottomed at $18.0 million in Q4 2024.
• Historically, Net Shares Issued and Repurchased has averaged $18.3 million across 3 years, with a median of $18.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased declined 3.86% in 2024, then changed 0.0% in 2025.
• Over 3 years, Net Shares Issued and Repurchased stood at $18.8 million in 2023, then slipped by 3.86% to $18.0 million in 2024, then changed by 0.0% to $18.0 million in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $18.0 million, $18.0 million, and $18.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.